.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Farmers Insurance
Dow
Merck
McKinsey
Harvard Business School
Fuji
Chinese Patent Office
Citi
Cipla

Generated: November 24, 2017

DrugPatentWatch Database Preview

Aytu Bioscience Inc Company Profile

« Back to Dashboard

What is the competitive landscape for AYTU BIOSCIENCE INC, and what generic alternatives to AYTU BIOSCIENCE INC drugs are available?

AYTU BIOSCIENCE INC has two approved drugs.

There are six US patents protecting AYTU BIOSCIENCE INC drugs.

There are thirty-five patent family members on AYTU BIOSCIENCE INC drugs in twenty-one countries.

Summary for Aytu Bioscience Inc

International Patents:35
US Patents:6
Tradenames:2
Ingredients:2
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aytu Bioscience Inc
NATESTO
testosterone
GEL, METERED;NASAL205488-001May 28, 2014RXNoNo► Subscribe► Subscribe► Subscribe
Aytu Bioscience Inc
NATESTO
testosterone
GEL, METERED;NASAL205488-001May 28, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Aytu Bioscience Inc
NATESTO
testosterone
GEL, METERED;NASAL205488-001May 28, 2014RXNoNo► Subscribe► SubscribeY ► Subscribe
Aytu Bioscience Inc
NATESTO
testosterone
GEL, METERED;NASAL205488-001May 28, 2014RXNoNo► Subscribe► SubscribeY ► Subscribe
Aytu Bioscience Inc
PRIMSOL
trimethoprim hydrochloride
SOLUTION;ORAL074973-001Jan 24, 2000RXYesYes► Subscribe► Subscribe ► Subscribe
Aytu Bioscience Inc
NATESTO
testosterone
GEL, METERED;NASAL205488-001May 28, 2014RXNoNo► Subscribe► SubscribeY ► Subscribe
Aytu Bioscience Inc
PRIMSOL
trimethoprim hydrochloride
SOLUTION;ORAL074973-001Jan 24, 2000RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Aytu Bioscience Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aytu Bioscience Inc
PRIMSOL
trimethoprim hydrochloride
SOLUTION;ORAL074973-001Jan 24, 2000► Subscribe► Subscribe
Aytu Bioscience Inc
PRIMSOL
trimethoprim hydrochloride
SOLUTION;ORAL074973-001Jan 24, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Premature patent expirations for AYTU BIOSCIENCE INC

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
► Subscribe ► Subscribe

Non-Orange Book Patents for Aytu Bioscience Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
2,014,073,618► Subscribe
9,579,280Controlled release delivery system for nasal applications and method of treatment► Subscribe
9,238,072Controlled release delivery system for nasal applications and method of treatment► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Aytu Bioscience Inc Drugs

Country Document Number Estimated Expiration
Japan4616270► Subscribe
Argentina047722► Subscribe
South Korea100861443► Subscribe
Japan2000505093► Subscribe
Australia727175► Subscribe
South Korea20060109903► Subscribe
Slovenia938302► Subscribe
Russian Federation2331423► Subscribe
TaiwanI350176► Subscribe
BrazilPI0416370► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
Boehringer Ingelheim
Covington
Farmers Insurance
Healthtrust
UBS
Fish and Richardson
Express Scripts
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot